152 related articles for article (PubMed ID: 37644061)
1. Early elevation of high-sensitivity C-reactive protein as a predictor for cardiovascular disease incidence and all-cause mortality: a landmark analysis.
Lee HS; Lee JH
Sci Rep; 2023 Aug; 13(1):14118. PubMed ID: 37644061
[TBL] [Abstract][Full Text] [Related]
2. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of high sensitivity C-reactive protein and triglyceride-glucose index on risk of cardiovascular disease among middle-aged and older Chinese: Evidence from the China Health and Retirement Longitudinal Study.
Feng G; Yang M; Xu L; Liu Y; Yu J; Zang Y; Shen S; Zheng X
Nutr Metab Cardiovasc Dis; 2023 Jun; 33(6):1245-1253. PubMed ID: 37095018
[TBL] [Abstract][Full Text] [Related]
4. High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis.
Zhang W; Speiser JL; Ye F; Tsai MY; Cainzos-Achirica M; Nasir K; Herrington DM; Shapiro MD
J Am Coll Cardiol; 2021 Sep; 78(11):1083-1094. PubMed ID: 34503676
[TBL] [Abstract][Full Text] [Related]
5. Cohort study of long working hours and increase in blood high-sensitivity C-reactive protein (hsCRP) concentration: Mechanisms of overwork and cardiovascular disease.
Lee W; Yim HW; Lee Y
J Occup Health; 2022 Jan; 64(1):e12359. PubMed ID: 36101013
[TBL] [Abstract][Full Text] [Related]
6. A novel protein glycan biomarker and future cardiovascular disease events.
Akinkuolie AO; Buring JE; Ridker PM; Mora S
J Am Heart Assoc; 2014 Sep; 3(5):e001221. PubMed ID: 25249300
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998.
Koenig W; Khuseyinova N; Baumert J; Meisinger C
Clin Chem; 2008 Feb; 54(2):335-42. PubMed ID: 18156284
[TBL] [Abstract][Full Text] [Related]
8. Prooxidant-antioxidant balance, hsTnI and hsCRP: mortality prediction in haemodialysis patients, two-year follow-up.
Antunovic T; Stefanovic A; Gligorovic Barhanovic N; Miljkovic M; Radunovic D; Ivanisevic J; Prelevic V; Bulatovic N; Ratkovic M; Stojanov M
Ren Fail; 2017 Nov; 39(1):491-499. PubMed ID: 28494192
[TBL] [Abstract][Full Text] [Related]
9. Effects of processed red meat consumption on the risk of type 2 diabetes and cardiovascular diseases among Korean adults: the Korean Genome and Epidemiology Study.
Son J; Lee Y; Park K
Eur J Nutr; 2019 Sep; 58(6):2477-2484. PubMed ID: 30069618
[TBL] [Abstract][Full Text] [Related]
10. High sensitive C-reactive protein (hsCRP), cardiovascular events and mortality in the aged: a prospective 9-year follow-up study.
Kuoppamäki M; Salminen M; Vahlberg T; Irjala K; Kivelä SL; Räihä I
Arch Gerontol Geriatr; 2015; 60(1):112-7. PubMed ID: 25456891
[TBL] [Abstract][Full Text] [Related]
11. Association of very highly elevated C-reactive protein concentration with cardiovascular events and all-cause mortality.
Hamer M; Chida Y; Stamatakis E
Clin Chem; 2010 Jan; 56(1):132-5. PubMed ID: 19884487
[TBL] [Abstract][Full Text] [Related]
12. Associations Between High-Sensitivity C-Reactive Protein and All-Cause Mortality Among Oldest-Old in Chinese Longevity Areas: A Community-Based Cohort Study.
Chen PL; Li ZH; Yang HL; Cao ZJ; Cheng X; Zhao F; Zhang XR; Lv YB; Li FR; Zhou YF; Li HN; Qu YL; Yin ZX; Liu L; Wu XB; Shi XM; Mao C
Front Public Health; 2022; 10():824783. PubMed ID: 35211447
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.
Sun J; Axelsson J; Machowska A; Heimbürger O; Bárány P; Lindholm B; Lindström K; Stenvinkel P; Qureshi AR
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1163-1172. PubMed ID: 27281698
[TBL] [Abstract][Full Text] [Related]
14. High-Sensitivity C-Reactive Protein and Risks of All-Cause and Cause-Specific Mortality in a Japanese Population.
Nisa H; Hirata A; Kohno M; Kiyohara C; Ohnaka K
Asian Pac J Cancer Prev; 2016; 17(5):2643-8. PubMed ID: 27268644
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the association between 35 frailty scores and cardiovascular events, cancer, and total mortality in an elderly general population in England: An observational study.
Aguayo GA; Vaillant MT; Donneau AF; Schritz A; Stranges S; Malisoux L; Chioti A; Guillaume M; Muller M; Witte DR
PLoS Med; 2018 Mar; 15(3):e1002543. PubMed ID: 29584726
[TBL] [Abstract][Full Text] [Related]
16. High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database.
Felix AS; Bower JK; Pfeiffer RM; Raman SV; Cohn DE; Sherman ME
Int J Cancer; 2017 Feb; 140(3):555-564. PubMed ID: 27741565
[TBL] [Abstract][Full Text] [Related]
17. Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups.
Georgakis MK; Malik R; Richardson TG; Howson JMM; Anderson CD; Burgess S; Hovingh GK; Dichgans M; Gill D
BMC Med; 2022 Aug; 20(1):245. PubMed ID: 35948913
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection.
Borges ÁH; O'Connor JL; Phillips AN; Neaton JD; Grund B; Neuhaus J; Vjecha MJ; Calmy A; Koelsch KK; Lundgren JD;
J Infect Dis; 2016 Aug; 214(3):408-16. PubMed ID: 27132283
[TBL] [Abstract][Full Text] [Related]
19. The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines.
Mora S; Musunuru K; Blumenthal RS
Clin Chem; 2009 Feb; 55(2):219-28. PubMed ID: 19095730
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
